Vera Therapeutics Inc (NASDAQ: VERA) open the trading on Wednesday, with great promise as it jumped 3.26% to $55.67, before settling in for the price of $53.91 at the close. Taking a more long-term approach, VERA posted a 52-week range of $18.53-$55.00.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 4.49%. Meanwhile, its Annual Earning per share during the time was 4.49%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -64.80%. This publicly-traded company’s shares outstanding now amounts to $63.89 million, simultaneously with a float of $53.33 million. The organization now has a market capitalization sitting at $3.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.27, while the 200-day Moving Average is $26.59.
Vera Therapeutics Inc (VERA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vera Therapeutics Inc’s current insider ownership accounts for 23.88%, in contrast to 83.58% institutional ownership. According to the most recent insider trade that took place on Dec 15 ’25, this organization’s Chief Regulatory Officer sold 10,000 shares at the rate of 50.08, making the entire transaction reach 500,767 in total value, affecting insider ownership by 22,500. Preceding that transaction, on Dec 11 ’25, Company’s Director bought 5,882 for 42.50, making the whole transaction’s value amount to 249,985. This particular insider is now the holder of 5,882 in total.
Vera Therapeutics Inc (VERA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.23 per share during the current fiscal year.
Vera Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -64.80% and is forecasted to reach -4.66 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.16% through the next 5 years, which can be compared against the 4.49% growth it accomplished over the previous five years trading on the market.
Vera Therapeutics Inc (NASDAQ: VERA) Trading Performance Indicators
Let’s observe the current performance indicators for Vera Therapeutics Inc (VERA). It’s Quick Ratio in the last reported quarter now stands at 12.09.
In the same vein, VERA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.99, a figure that is expected to reach -1.28 in the next quarter, and analysts are predicting that it will be -4.66 at the market close of one year from today.
Technical Analysis of Vera Therapeutics Inc (VERA)
[Vera Therapeutics Inc, VERA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 93.23% While, its Average True Range was 86.10.
Raw Stochastic average of Vera Therapeutics Inc (VERA) in the period of the previous 100 days is set at 98.97%, which indicates a major rise in contrast to 97.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.94 that was higher than 1.79 volatility it exhibited in the past 100-days period.
